Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 10, 2005 - Issue 2
Submit an article Journal homepage
93
Views
5
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for bacterial urinary tract infections

Florian ME WagenlehnerHospital St. Elisabeth Urologic Clinic, St. Elisabeth Street. 23, D-94315, Straubing GermanyTel: + 49 9421 710 6702; Fax: + 49 9421 710 1717;E-mail: [email protected]
,
Wolfgang WeidnerUniversity Giessen Department of Urology, Rudolf-Buchheim-Street. 7, D-35385, Giessen Germany
&
Kurt G NaberHospital St. Elisabeth Urologic Clinic, St. Elisabeth Street. 23, D-94315, Straubing GermanyTel: + 49 9421 710 6702; Fax: + 49 9421 710 1717;E-mail: [email protected]
Pages 275-298 | Published online: 10 May 2005

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Anne Boyina Sravani, Mangala Shenoy K.Baby Chandrika, Harish Kumar B.Suvarna G. Kini, Sreedhara Ranganatha Pai K.Shaila A. Lewis. (2023) Curcumin-sulfobutyl-ether beta cyclodextrin inclusion complex: preparation, spectral characterization, molecular modeling, and antimicrobial activity. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now

Articles from other publishers (4)

Jia-Yu Zeng, Yu-Qi Liang, Yan-Ni Wu, Xiao-Yi Wu, Jia-Ping Lai & Hui Sun. (2022) Synthesis and application of novel N, Si-carbon dots for the ratiometric fluorescent monitoring of the antibiotic balofloxacin in tablets and serum. RSC Advances 12:45, pages 29585-29594.
Crossref
Francisco Cruz, Miriam Dambros, Kurt G. Naber, Hartwig W. Bauer & Gabriel Cozma. (2009) Recurrent Urinary Tract Infections: Uro-Vaxom?, a New Alternative. European Urology Supplements 8:9, pages 762-768.
Crossref
L. Gualco, A.M. Schito, G.C. Schito & A. Marchese. (2007) In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance. International Journal of Antimicrobial Agents 29:6, pages 679-687.
Crossref
Simona Roveta, Anna Maria Schito, Anna Marchese & Gian Carlo Schito. (2005) Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 26:5, pages 366-372.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.